Evidence map›Paper›PMID 21813699›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2.

Jordan M Blacktop, Chad Seubert, David A Baker, Nathan Ferda, Geng Lee, Evan N Graf, John R Mantsch

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 105 citations in OpenAlex.

  1. Review
  2. Article
  3. Aversion-induced dopamine reductions predict drug-taking and escape behaviors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Animal Models of the Behavioral Symptoms of Substance Use Disorders.Cold Spring Harbor perspectives in medicine · 2021
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Addiction is driven by excessive goal-directed drug choice under negative affect: translational critique of habit and compulsion theory.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Review
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jordan M BlacktopDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53201, USA.
Chad Seubert
David A Baker
Nathan Ferda
Geng Lee
Evan N Graf
John R Mantsch
Marquette University · US

Funding

Stress response and HPA regulation in cocaine addictionR01DA015758 · NIDA · MARQUETTE UNIVERSITY · PI MANTSCH, JOHN R. · 2002 to 2014
$2.8M
Targeting System Xc- for the Treatment of AddictionR01DA025617 · NIDA · MARQUETTE UNIVERSITY · PI BAKER, DAVID A, COOK, JAMES M · 2009 to 2010
$1.4M
Cystine-Glutamate Antiporters and Cocaine ReinstatementR01DA017328 · NIDA · MARQUETTE UNIVERSITY · PI BAKER, DAVID A · 2004 to 2008
$1.4M
NIDA NIH HHS DA025617NIDA NIH HHS DA15758NIDA NIH HHS R01 DA015758NIDA NIH HHS R01 DA017328NIDA NIH HHS R01 DA025617
6 · The paper itself

Abstract

Stressful events are determinants of relapse in recovering cocaine addicts. Excessive cocaine use may increase susceptibility to stressor-induced relapse through alterations in brain corticotropin-releasing factor (CRF) regulation of neurocircuitry involved in drug seeking. We previously reported that the reinstatement of cocaine seeking by a stressor (footshock) is CRF dependent and is augmented in rats that self-administered cocaine under long-access (LgA; 6 h daily) conditions for 14 d when compared with rats provided shorter daily cocaine access [short access (ShA) rats; 2 h daily]. Further, we have demonstrated that reinstatement in response to intracerebroventricular CRF administration is heightened in LgA rats. This study examined the role of altered ventral tegmental area (VTA) responsiveness to CRF in intake-dependent increases in CRF- and stress-induced cocaine seeking. Bilateral intra-VTA administration of CRF (250 or 500 ng/side) produced reinstatement in LgA but not ShA rats. In LgA rats, intra-VTA CRF-induced reinstatement was blocked by administration of the CRF-receptor type 1 (CRF-R1) antagonist antalarmin (500 ng/side) or CP-376395 (500 ng/side), but not the CRF-R2 antagonist astressin-2B (500 ng or 1 μg/side) or antisauvagine-30 (ASV-30; 500 ng/side) into the VTA. Likewise, intra-VTA antalarmin, but not astressin-2B, blocked footshock-induced reinstatement in LgA rats. By contrast, neither intra-VTA antalarmin nor CP-376395 altered food-reinforced lever pressing. Intra-VTA injection of the CRF-R1-selective agonist cortagine (100 ng/side) but not the CRF-R2-selective agonist rat urocortin II (rUCN II; 250 ng/side) produced reinstatement. These findings reveal that excessive cocaine use increases susceptibility to stressor-induced relapse in part by augmenting CRF-R1-dependent regulation of addiction-related neurocircuitry in the VTA.

Indexed as

AminopyridinesAnalysis of VarianceAnimalsBehavior, AddictiveBehavior, AnimalCocaineConditioning, OperantCorticotropin-Releasing HormoneDopamine Uptake InhibitorsDose-Response Relationship, DrugDrug SynergismExtinction, PsychologicalFlavonoidsFood PreferencesGlucosidesMale(3,6-dimethyl-2-(2,4,6-trimethylphenoxy)pyridin-4-yl)(1-ethylpropyl)amineAminopyridinesantalarminantisauvagine 30astressin-2BCocaineCorticotropin-Releasing HormoneDopamine Uptake InhibitorsFlavonoidsGlucosidesliquiritigenin-7-O-beta-D-apiofuranosyl-4'-O-beta-D-glucopyranosidePeptide FragmentsPeptides, CyclicPyrimidinesPyrrolesReceptors, Corticotropin-Releasing Hormone

Identifiers

PMID21813699
PMCPMC3449095
OpenAlexW2156623031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.